Axcella Health Inc.
AXLADelisted Feb 15, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001633070
Axcella Health Inc. was delisted on Feb 15, 2024; its insiders filed their last Form 4 on Mar 3, 2023; 15 institutions reported holding it in 13F filings for Q3 2023, worth $17.1M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Axcella Health Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 35 | 29 | −6 |
| Shares | 49.2M | 49.1M | −84.7K (−0.2%) |
| Value | $15.9M | $23.6M | +$7.67M (+48.3%) |
New holders (3)
Institutions that held Axcella Health Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 83,456 | $40.0K | 0.00% |
| UBS Group AG | 6,217 | $2.98K | 0.00% |
| Simplex Trading, LLC | 2,312 | $1.00K | 0.00% |
Sold out (9)
Institutions that held Axcella Health Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Shay Capital LLC | 50,000 | $16.4K |
| Jane Street Group, LLC | 32,140 | $10.5K |
| Susquehanna International Group, LLP | 23,300 | $7.63K |
| Citadel Advisors LLC | 17,837 | $5.84K |
| StoneX Group Inc. | 15,000 | $4.91K |
| Connor, Clark & Lunn Investment Management Ltd. | 13,979 | $4.58K |
| First Manhattan Co | 2,000 | $655 |
| Money Concepts Capital Corp | 530 | $174 |
| BNP Paribas Arbitrage, SA | 2 | $1 |